WINT logo

Windtree Therapeutics (WINT) Cash From Operations

Annual CFO

-$13.44 M
+$6.01 M+30.92%

December 31, 2023


Summary


Performance

WINT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWINTcash flowmetrics:

Quarterly CFO

-$6.44 M
-$4.12 M-177.04%

September 30, 2024


Summary


Performance

WINT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWINTcash flowmetrics:

TTM CFO

-$15.28 M
-$2.59 M-20.40%

September 30, 2024


Summary


Performance

WINT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWINTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WINT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.9%-67.2%-15.3%
3 y3 years+46.9%-155.8%-0.2%
5 y5 years+14.8%-155.8%-0.2%

WINT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.2%-177.0%+4.0%-20.4%+37.2%
5 y5-yearat high+46.9%-177.0%+21.9%-20.4%+41.8%
alltimeall time-140.0%+76.7%-110.7%+77.0%-134.7%+76.0%

Windtree Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.44 M(+177.0%)
-$15.28 M(+20.4%)
Jun 2024
-
-$2.33 M(-21.1%)
-$12.69 M(-8.4%)
Mar 2024
-
-$2.95 M(-17.4%)
-$13.87 M(+3.2%)
Dec 2023
-$13.44 M(-30.9%)
-$3.57 M(-7.4%)
-$13.44 M(+1.4%)
Sep 2023
-
-$3.85 M(+10.2%)
-$13.25 M(-1.8%)
Jun 2023
-
-$3.50 M(+38.8%)
-$13.49 M(-11.5%)
Mar 2023
-
-$2.52 M(-25.5%)
-$15.26 M(-21.6%)
Dec 2022
-$19.45 M(-17.8%)
-$3.38 M(-17.5%)
-$19.45 M(-7.4%)
Sep 2022
-
-$4.10 M(-22.0%)
-$21.00 M(-5.3%)
Jun 2022
-
-$5.26 M(-21.7%)
-$22.19 M(-8.8%)
Mar 2022
-
-$6.71 M(+36.2%)
-$24.33 M(+2.8%)
Dec 2021
-$23.66 M(-6.5%)
-$4.93 M(-6.6%)
-$23.66 M(+1.7%)
Sep 2021
-
-$5.28 M(-28.7%)
-$23.27 M(-11.3%)
Jun 2021
-
-$7.40 M(+22.4%)
-$26.25 M(+1.4%)
Mar 2021
-
-$6.05 M(+33.2%)
-$25.88 M(+2.2%)
Dec 2020
-$25.32 M(+2.6%)
-$4.54 M(-45.0%)
-$25.32 M(-3.5%)
Sep 2020
-
-$8.26 M(+17.3%)
-$26.23 M(+20.3%)
Jun 2020
-
-$7.04 M(+28.4%)
-$21.80 M(+1.9%)
Mar 2020
-
-$5.48 M(+0.4%)
-$21.39 M(-13.3%)
Dec 2019
-$24.66 M(+56.3%)
-$5.46 M(+42.8%)
-$24.66 M(-2.9%)
Sep 2019
-
-$3.82 M(-42.2%)
-$25.39 M(+2.2%)
Jun 2019
-
-$6.62 M(-24.4%)
-$24.85 M(+13.0%)
Mar 2019
-
-$8.76 M(+41.5%)
-$21.99 M(+39.4%)
Dec 2018
-$15.78 M(-25.0%)
-$6.19 M(+88.9%)
-$15.78 M(+9.6%)
Sep 2018
-
-$3.28 M(-13.0%)
-$14.40 M(-0.7%)
Jun 2018
-
-$3.77 M(+47.9%)
-$14.50 M(-10.8%)
Mar 2018
-
-$2.55 M(-47.0%)
-$16.26 M(-22.7%)
Dec 2017
-$21.05 M(-162.7%)
-$4.81 M(+42.4%)
-$21.05 M(-147.8%)
Sep 2017
-
-$3.38 M(-38.9%)
$44.00 M(+12.7%)
Jun 2017
-
-$5.53 M(-24.6%)
$39.04 M(+10.2%)
Mar 2017
-
-$7.33 M(-112.2%)
$35.44 M(+5.5%)
Dec 2016
$33.59 M(-200.3%)
$60.23 M(-822.9%)
$33.59 M(-198.0%)
Sep 2016
-
-$8.33 M(-8.7%)
-$34.29 M(+2.4%)
Jun 2016
-
-$9.13 M(-0.6%)
-$33.48 M(-1.6%)
Mar 2016
-
-$9.19 M(+20.1%)
-$34.03 M(+1.6%)
Dec 2015
-$33.50 M(-18.6%)
-$7.65 M(+1.6%)
-$33.50 M(-6.8%)
Sep 2015
-
-$7.52 M(-22.3%)
-$35.94 M(-8.4%)
Jun 2015
-
-$9.68 M(+11.7%)
-$39.25 M(-0.8%)
Mar 2015
-
-$8.66 M(-14.1%)
-$39.55 M(-3.9%)
Dec 2014
-$41.17 M(+1.8%)
-$10.08 M(-6.9%)
-$41.17 M(+0.1%)
Sep 2014
-
-$10.83 M(+8.5%)
-$41.12 M(+2.1%)
Jun 2014
-
-$9.98 M(-2.9%)
-$40.27 M(-0.6%)
Mar 2014
-
-$10.28 M(+2.4%)
-$40.50 M(+0.1%)
Dec 2013
-$40.45 M(+23.0%)
-$10.03 M(+0.6%)
-$40.45 M(+2.5%)
Sep 2013
-
-$9.98 M(-2.3%)
-$39.48 M(+0.3%)
Jun 2013
-
-$10.21 M(-0.3%)
-$39.36 M(+4.7%)
Mar 2013
-
-$10.23 M(+12.9%)
-$37.57 M(+14.3%)
Dec 2012
-$32.88 M(+44.9%)
-$9.06 M(-8.0%)
-$32.88 M(+12.1%)
Sep 2012
-
-$9.85 M(+16.9%)
-$29.34 M(+15.0%)
Jun 2012
-
-$8.42 M(+51.9%)
-$25.53 M(+10.1%)
Mar 2012
-
-$5.55 M(+0.4%)
-$23.18 M(+2.1%)
Dec 2011
-$22.70 M(-6.5%)
-$5.52 M(-8.4%)
-$22.70 M(-0.4%)
Sep 2011
-
-$6.03 M(-0.7%)
-$22.78 M(+5.0%)
Jun 2011
-
-$6.07 M(+19.8%)
-$21.69 M(-5.4%)
Mar 2011
-
-$5.07 M(-9.6%)
-$22.94 M(-5.5%)
Dec 2010
-$24.27 M(-11.5%)
-$5.61 M(+13.4%)
-$24.27 M(-1.5%)
Sep 2010
-
-$4.95 M(-32.5%)
-$24.64 M(-6.4%)
Jun 2010
-
-$7.32 M(+14.4%)
-$26.31 M(+0.1%)
Mar 2010
-
-$6.40 M(+7.0%)
-$26.30 M(-4.1%)
DateAnnualQuarterlyTTM
Dec 2009
-$27.41 M(-13.7%)
-$5.98 M(-9.6%)
-$27.41 M(-6.5%)
Sep 2009
-
-$6.62 M(-9.4%)
-$29.32 M(+2.5%)
Jun 2009
-
-$7.30 M(-2.9%)
-$28.60 M(+1.0%)
Mar 2009
-
-$7.52 M(-4.6%)
-$28.31 M(-10.9%)
Dec 2008
-$31.75 M(+8.0%)
-$7.88 M(+33.7%)
-$31.75 M(-0.9%)
Sep 2008
-
-$5.89 M(-15.9%)
-$32.05 M(-2.0%)
Jun 2008
-
-$7.01 M(-36.1%)
-$32.71 M(-0.5%)
Mar 2008
-
-$10.96 M(+33.9%)
-$32.87 M(+11.8%)
Dec 2007
-$29.39 M(-26.2%)
-$8.19 M(+25.0%)
-$29.39 M(+4.5%)
Sep 2007
-
-$6.55 M(-8.7%)
-$28.12 M(-1.4%)
Jun 2007
-
-$7.17 M(-4.3%)
-$28.52 M(-16.4%)
Mar 2007
-
-$7.49 M(+8.4%)
-$34.13 M(-14.3%)
Dec 2006
-$39.83 M(-30.9%)
-$6.91 M(-0.6%)
-$39.83 M(-34.6%)
Sep 2006
-
-$6.95 M(-45.6%)
-$60.88 M(-4.5%)
Jun 2006
-
-$12.78 M(-3.1%)
-$63.76 M(+6.3%)
Mar 2006
-
-$13.19 M(-52.8%)
-$60.00 M(+4.0%)
Dec 2005
-$57.66 M(+73.0%)
-$27.96 M(+184.3%)
-$57.66 M(+56.2%)
Sep 2005
-
-$9.84 M(+9.1%)
-$36.92 M(+3.3%)
Jun 2005
-
-$9.01 M(-17.0%)
-$35.75 M(+0.3%)
Mar 2005
-
-$10.86 M(+50.5%)
-$35.63 M(+6.9%)
Dec 2004
-$33.34 M(+42.1%)
-$7.22 M(-16.7%)
-$33.34 M(-1.6%)
Sep 2004
-
-$8.66 M(-2.6%)
-$33.89 M(+9.3%)
Jun 2004
-
-$8.89 M(+3.8%)
-$31.02 M(+14.8%)
Mar 2004
-
-$8.57 M(+10.3%)
-$27.01 M(+15.1%)
Dec 2003
-$23.46 M(+71.9%)
-$7.77 M(+34.2%)
-$23.46 M(+19.3%)
Sep 2003
-
-$5.79 M(+18.5%)
-$19.66 M(+10.3%)
Jun 2003
-
-$4.88 M(-2.8%)
-$17.82 M(+4.2%)
Mar 2003
-
-$5.02 M(+26.5%)
-$17.10 M(+25.3%)
Dec 2002
-$13.65 M(+7.9%)
-$3.97 M(+0.6%)
-$13.65 M(-0.6%)
Sep 2002
-
-$3.94 M(-5.2%)
-$13.73 M(+10.0%)
Jun 2002
-
-$4.16 M(+164.8%)
-$12.48 M(+11.8%)
Mar 2002
-
-$1.57 M(-61.2%)
-$11.16 M(-11.7%)
Dec 2001
-$12.64 M(+115.9%)
-$4.05 M(+50.2%)
-$12.64 M(+25.7%)
Sep 2001
-
-$2.70 M(-5.0%)
-$10.06 M(+14.0%)
Jun 2001
-
-$2.84 M(-7.1%)
-$8.83 M(+14.4%)
Mar 2001
-
-$3.06 M(+108.6%)
-$7.71 M(+31.7%)
Dec 2000
-$5.86 M(+41.6%)
-$1.47 M(0.0%)
-$5.86 M(+29.3%)
Sep 2000
-
-$1.47 M(-15.3%)
-$4.53 M(+6.2%)
Jun 2000
-
-$1.73 M(+44.4%)
-$4.26 M(+14.2%)
Mar 2000
-
-$1.20 M(+773.7%)
-$3.73 M(-9.7%)
Dec 1999
-$4.14 M(-39.2%)
-$137.00 K(-88.6%)
-$4.14 M(-23.4%)
Sep 1999
-
-$1.20 M(0.0%)
-$5.40 M(-1.8%)
Jun 1999
-
-$1.20 M(-25.0%)
-$5.50 M(-15.4%)
Mar 1999
-
-$1.60 M(+14.3%)
-$6.50 M(-4.4%)
Dec 1998
-$6.80 M(+36.0%)
-$1.40 M(+7.7%)
-$6.80 M(-21.8%)
Sep 1998
-
-$1.30 M(-40.9%)
-$8.70 M(+31.8%)
Jun 1998
-
-$2.20 M(+15.8%)
-$6.60 M(+4.8%)
Mar 1998
-
-$1.90 M(-42.4%)
-$6.30 M(+26.0%)
Dec 1997
-$5.00 M(+138.1%)
-$3.30 M(-512.5%)
-$5.00 M(+108.3%)
Sep 1997
-
$800.00 K(-142.1%)
-$2.40 M(-36.8%)
Jun 1997
-
-$1.90 M(+216.7%)
-$3.80 M(+58.3%)
Mar 1997
-
-$600.00 K(-14.3%)
-$2.40 M(+14.3%)
Dec 1996
-$2.10 M(-16.0%)
-$700.00 K(+16.7%)
-$2.10 M(+50.0%)
Sep 1996
-
-$600.00 K(+20.0%)
-$1.40 M(+75.0%)
Jun 1996
-
-$500.00 K(+66.7%)
-$800.00 K(-33.3%)
Mar 1996
-
-$300.00 K(-66.7%)
-$1.20 M(0.0%)
Dec 1995
-$2.50 M
-
-
Jun 1995
-
-$900.00 K(+200.0%)
-$1.20 M(+300.0%)
Mar 1995
-
-$300.00 K
-$300.00 K

FAQ

  • What is Windtree Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Windtree Therapeutics?
  • What is Windtree Therapeutics annual CFO year-on-year change?
  • What is Windtree Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Windtree Therapeutics?
  • What is Windtree Therapeutics quarterly CFO year-on-year change?
  • What is Windtree Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Windtree Therapeutics?
  • What is Windtree Therapeutics TTM CFO year-on-year change?

What is Windtree Therapeutics annual cash flow from operations?

The current annual CFO of WINT is -$13.44 M

What is the all time high annual CFO for Windtree Therapeutics?

Windtree Therapeutics all-time high annual cash flow from operations is $33.59 M

What is Windtree Therapeutics annual CFO year-on-year change?

Over the past year, WINT annual cash flow from operations has changed by +$6.01 M (+30.92%)

What is Windtree Therapeutics quarterly cash flow from operations?

The current quarterly CFO of WINT is -$6.44 M

What is the all time high quarterly CFO for Windtree Therapeutics?

Windtree Therapeutics all-time high quarterly cash flow from operations is $60.23 M

What is Windtree Therapeutics quarterly CFO year-on-year change?

Over the past year, WINT quarterly cash flow from operations has changed by -$2.59 M (-67.20%)

What is Windtree Therapeutics TTM cash flow from operations?

The current TTM CFO of WINT is -$15.28 M

What is the all time high TTM CFO for Windtree Therapeutics?

Windtree Therapeutics all-time high TTM cash flow from operations is $44.00 M

What is Windtree Therapeutics TTM CFO year-on-year change?

Over the past year, WINT TTM cash flow from operations has changed by -$2.03 M (-15.35%)